Tag: Astrazeneca
Market: AstraZeneca could eventually release vaccines, no regrets about COVID, says its CEO
by Aimee Donnellan and Natalie Grover LONDON (Reuters) – AstraZeneca could eventually release vaccines, its chief executive told Reuters on Tuesday, in a significant turnaround for the company, one of…
AstraZeneca: Will present new data in oncology
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: in the green, a broker raises its target
(CercleFinance.com) – AstraZeneca gains nearly 1% in London, supported by an analysis by AlphaValue which announced on Monday that it has raised its opinion on the stock, which it is…
AstraZeneca: AlphaValue raises its opinion to ‘accumulate’
(CercleFinance.com) – AlphaValue announced on Monday that it has raised its opinion on AstraZeneca, which it is changing from ‘reduce’ to ‘accumulate’ with a price target maintained at 12,896 pence.…
AstraZeneca: AlphaValue raises its opinion to ‘accumulate’
AlphaValue announced on Monday that it has raised its opinion on AstraZeneca, which it is changing from ‘lighten’ to ‘accumulate’ with a price target maintained at 12,896 pence. In a…
AstraZeneca: priority review for Lynparza in the USA
(CercleFinance.com) – AstraZeneca announced on Thursday that its cancer tablet Lynparza will receive priority review in the United States for the treatment of metastatic castration-resistant prostate cancer (mCRPC). Lynparza, developed…
AstraZeneca: positive results in breast cancer
(CercleFinance.com) – AstraZeneca announced on Monday that Enhertu, the antibody-conjugate it is developing with the Japanese Daiichi Sankyo, had given positive results in a trial conducted on patients suffering from…
AstraZeneca: FDA extends Enhertu approval
AstraZeneca announced Friday that the US FDA had approved Enhertu, the antibody-conjugate it developed with Japanese Daiichi Sankyo, in the treatment of lung cancer. The biopharmaceutical group specifies that the…
AstraZeneca: promising results in lung cancer
(CercleFinance.com) – AstraZeneca and its Japanese partner Daiichi Sankyo reported encouraging results on Tuesday for their experimental drug Datopotamab Deruxtecan in the treatment of advanced non-small cell lung cancer. According…
AstraZeneca: Encouraging results for Tagrisso
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
AstraZeneca: Enhertu approval extended to the United States
(CercleFinance.com) – AstraZeneca announced on Monday that it had received the green light from the American Food and Drug Administration (FDA) for the marketing of its immunotherapy Enhertu in the…
AstraZeneca: FDA approves Calquence tablets
(CercleFinance.com) – AstraZeneca announced Friday the approval by the FDA of Calquence tablets for the same indications as those existing for the capsule version of the drug. The biopharmaceutical group…